Embassy Developments Product Launch

Embassy Developments Other Announcement

Embassy Developments Ltd filed its shareholding pattern as of 30-Oct-2026, showing promoter holding of about 42.46%. Promoter holding also shows a 0.0153% stake in the table, which is routine quarterly disclosure.

Embassy Developments Earnings Call Transcript: Key Takeaways

Embassy reports record-high pre-sales and luxury launches, though project completion accounting hides operational momentum behind a net loss.

Embassy Developments Investor Presentation: Key Takeaways

Q2FY27 record pre-sales INR 3,225 Cr (+689% YoY), but revenue fell 41% to INR 292 Cr and PAT loss widened to INR 271 Cr. Net debt INR 3,982 Cr; collections inflection expected FY28.

Embassy Developments Business Update

Embassy Developments reported record Q2 FY27 pre-sales of ₹3,225 crore, up 272% QoQ. Three launches carried a combined GDV of ₹8,397 crore.

Embassy Developments Q2 FY27 Results: Net Loss of ₹271.2 Cr, Loss Widens

Embassy Developments Ltd reported revenue from operations of ₹292.2 Cr (-40.9% YoY) and a net loss of ₹271.2 Cr for Q2 FY27.

Key figure

Net loss ₹271.2 Cr

Embassy Developments Convertible Warrants

Embassy Developments allotted 93,18,900 equity shares to promoter group entity Embassy Property Developments on conversion of warrants. The company received the balance consideration of about Rs.77.94 Crore, completing the warrant conversion.

Value

₹77.94 Cr

HCL Technologies Product Launch

HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.

Morepen Laboratories Product Launch

Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.

AstraZeneca Pharma India Product Launch

AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.

Raama Finance Product Launch

Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.

Puravankara Product Launch

Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.

JBM Auto Product Launch

JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.

electric bus manufacturing capacity

20000.0 buses per annum